Table 2. Radioembolization data of the 119 patients.

Characteristic		Data
Glass		90 (75.6)
Resin		29 (24.4)
Number of treated vessels*		3 (2–4)
	1	16 (13.4)
	2	35 (29.4)
	3	28 (23.5)
	4	20 (16.8)
	5 or more	20 (16.8)
Treated vessel level
	Lobar	14 (11.8)
	Lobar + segmental	8 (6.7)
	Lobar + subsegmental	11 (9.2)
	Lobar + segmental + subsegmental	9 (7.6)
	Segmental	33 (27.7)
	Segmental + subsegmental	43 (36.1)
	Subsegmental	1 (0.8)
Lung shunt fraction, %		4.1 (2.2–6.6)
Lung dose, Gy		8.8 (4.9–17.1)
Total radiation activity delivered, GBq		4.7 (3.3–6.2)
Total liver volume, mL		1,518 (1,268–1,856)
Treated liver volume, mL		877 (672–1,213)
Tumor volume, mL		366 (167–640)
mAD, Gy		231 (169–318)
Pre-treatment TAD on SPECT/CT, Gy		416 (278–588)
Post-treatment TAD on PET/CT, Gy		582 (374–778)

Data are presented as number of patients (%) or median (interquartile range).

^*The full range was 1–9.

mAD = mean absorbed dose to the treated volume, TAD = tumor absorbed dose, SPECT = single-photon emission computed tomography